Exchange: NASDAQ·Updated 07:30 PM EDT

NDSN News

News
all
press releases
Here's Why You Should Consider Investing in Nordson Stock Now
NDSN's strong end-market demand, strategic acquisitions and raised fiscal 2026 guidance boost its growth prospects. Is the stock worth buying now?
Zacks
Here's Why You Should Consider Investing in Nordson Stock Now
NDSN's strong end-market demand, strategic acquisitions and raised fiscal 2026 guidance boost its growth prospects. Is the stock worth buying now?
Zacks
More News
MWA or NDSN: Which Is the Better Value Stock Right Now?
MWA vs. NDSN: Which Stock Is the Better Value Option?
Zacks
Reasons Why Investors Should Consider Investing in Helios Stock
HLIO is benefiting from improving demand, margin expansion and shareholder returns, with 2026 earnings expected to rise 24.6%.
Zacks
Reasons Why Investors Should Consider Investing in Nordson Stock
NDSN is benefiting from broad-based business strength, acquisition gains and shareholder returns as it invests in long-term growth.
Zacks
Nordson (NDSN) Down 6.9% Since Last Earnings Report: Can It Rebound?
Nordson (NDSN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
MWA or NDSN: Which Is the Better Value Stock Right Now?
MWA vs. NDSN: Which Stock Is the Better Value Option?
Zacks
Are Industrial Products Stocks Lagging Helios Technologies (HLIO) This Year?
Here is how Helios Technologies (HLIO) and Nordson (NDSN) have performed compared to their sector so far this year.
Zacks
Nordson's 2026 Outlook: Recurring Revenue Base Drives Sustained Long-Term Profitability
Key PointsNordson maintains a critical role in semiconductor packaging and medical device manufacturing hardware...
Nasdaq News: Markets
Top Research Reports for S&P Global, Cloudflare & Canadian Natural
Cloudflare's enterprise demand, AI-driven adoption and raised 2026 outlook support growth, but margin pressure and competition keep risk balanced.
Zacks
Buy 3 Manufacturing Robotics Bigwigs Amid Solid Price Upside Potential
EMR, NDSN and ZBRA offer double-digit short-term upside, backed by automation demand and solid growth prospects.
Zacks

Advertisement|Remove ads.